TOMSK, RUSSIA / RankWire.AI / – Russian scientists have explored a bioactive coating aimed at optimizing the interaction between titanium orthopaedic implants and bone tissue. This innovative material incorporates calcium phosphate derived from hydroxyapatite and features nitrogen compounds linked to nitric oxide production. Laboratory experiments revealed a marked increase in the survival rate of human mesenchymal stem cells on coated surfaces compared to uncoated titanium. The research team assessed the coating’s structure, chemistry, mechanical attributes, and biological responses. Their peer-reviewed results appeared in Applied Surface Science in 2026.
Researchers at Tomsk Polytechnic University created the experimental coatings through reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They manipulated the nitrogen and argon gas ratios during deposition to observe how each mixture influenced the surface properties. The study tested five different conditions, from pure nitrogen to pure argon. Subsequently, the team measured coating thickness, surface morphology, hardness, wettability, and chemical composition. They also performed laboratory tests to evaluate how living human cells reacted to the modified titanium surfaces.
Findings demonstrated that the amount of argon influenced multiple physical characteristics of the coatings. Surfaces produced with pure argon proved denser and harder than those deposited with pure nitrogen. Moreover, the coating thickness increased proportionally with the rise in argon concentration. Chemical analysis detected nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared human mesenchymal stem cells grown on coated titanium with those on uncoated titanium, focusing on cell viability and markers indicative of bone-cell development.
Cell Survival Significantly Improved by Coating Tests
Results from cell experiments showed that coated surfaces significantly outperformed uncoated titanium in cell survival rates, according to the study. After seven days, coatings with higher nitrogen content also suppressed activity in specific genes related to early bone-cell differentiation. Despite this, the cells maintained their potential for bone formation. The experiments were carried out under controlled laboratory conditions using human mesenchymal stem cells, and the study did not involve testing in patients nor did it evaluate the clinical performance of actual implanted medical devices.
The biomedical assessment was carried out by Immanuel Kant Baltic Federal University alongside Siberian State Medical University. Researchers from Saint Petersburg State University also contributed to this broader investigation. Funding for the project was provided through Russia’s national science program. The primary goal was to identify gas mixtures capable of producing coatings with advantageous physical, chemical, and biological properties. Hydroxyapatite is already used in implant coatings because its calcium phosphate makeup resembles the mineral component found naturally in human bone.
Further Testing Still Needed Before Clinical Application
The research team has outlined plans for additional investigations beyond the initial seven-day cell experiments. They intend to study stem cells over periods of 10 to 28 days, analyze the dissolution rate of the coatings, and measure nitric oxide release into surrounding tissue in living organisms. These aspects were not part of the published laboratory results. Currently, the focus remains on coated titanium substrates, their physical and chemical properties, and in vitro cell responses, rather than on clinical outcomes in orthopaedic patients.
The data obtained offers a detailed view of how different ratios of nitrogen and argon impact calcium phosphate coatings on titanium surfaces. Variations in thickness, density, hardness, chemical bonding, and cellular responses across the tested gas mixtures were documented. The results also confirmed that coated samples supported greater stem-cell survival compared to uncoated titanium under laboratory conditions. Nevertheless, the research remains in the preclinical stage, and the experiments do not determine safety or effectiveness in humans. Future biological studies will explore additional properties not addressed in the current research.